Ontology highlight
ABSTRACT: Background
Age-related macular degeneration (AMD) is a common cause of visual impairment in individuals >55 years of age worldwide. The varying clinical phenotypes of AMD result from contributions of genetic, epigenetic, and nongenetic (environmental) factors. Genetic studies of AMD have come of age as a direct result of tremendous gains from the human genome project, genome-wide association studies, and identification of numerous susceptibility loci. These findings have implicated immune response, high-density lipoprotein cholesterol metabolism, extracellular matrix, and angiogenesis signaling pathways in disease pathophysiology.Main outcome measures
Herein, we address how the wealth of genetic findings in AMD is expected to impact the practice of medicine, providing oppor
SUBMITTER: Priya RR
PROVIDER: S-EPMC3514599 | biostudies-literature | 2012 Dec
REPOSITORIES: biostudies-literature